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EssayTwo clichés of science journalism have now played out around the ENCODE 
project. ENCODE’s publicity first presented a misleading “all the textbooks 
are wrong” narrative about noncoding human DNA. Now several critiques 
of ENCODE’s narrative have been published, and one was so vitriolic that it 
fueled “undignified academic squabble” stories that focused on tone more 
than substance. Neither story line does justice to our actual understanding of 
genomes, to ENCODE’s results, or to the role of big science in biology. 
The ENCODE project: Missteps 
overshadowing a successSean R. Eddy 
The Encyclopedia of DNA Elements 
or ‘ENCODE’ project has aimed to 
catalog all functional elements in 
the human genome, where ‘all’ and 
‘functional element’ should both 
be in scare quotes. In genomics, 
all is a term of art, meaning 
reasonably comprehensive. Even 
complete genome sequences only 
asymptotically approach actual 
completeness, despite being well 
defined goals of known and finite 
size. ENCODE’s goal was much 
more nebulous, because there are 
three senses in which ‘functional 
element’ is ill defined and had to be 
operationalized.
First, ENCODE had to choose 
a specific set of genome-wide 
biochemical assays as proxies 
for biological function. ENCODE 
assayed the locations of RNA 
transcription, of several DNA-binding 
proteins, of several specific histone 
modifications, and of DNase I 
hypersensitivity sites.
Second, different functional 
elements are active in different 
conditions: different cell types, 
developmental stages, environmental 
conditions, ad infinitum. ENCODE 
had to limit the scope of different cell 
types and conditions it examined. Its 
assays were run primarily on a small 
number of cultured cell lines: three 
cell types in particular (two immortal 
cancer cell lines and an embryonic 
stem cell line), and to lesser extent 
on 144 other cell types.
Third, biological phenomena 
are generally a continuum — for 
example, a DNA-binding protein 
binds all possible DNA sequences, 
albeit with different affinities. The 
continuous quantitative terrain of 
each ENCODE assay’s results was converted into discrete ‘functional 
elements’ by choosing statistical 
thresholds based on reproducibility 
across replicates.
The results, published 
simultaneously in 30 papers [1], 
consist of a matrix of assays versus 
cell types, totalling 1640 datasets. 
Each dataset can be laid as a track 
of discrete boxes along the human 
genome, showing the genomic 
locations of all the reproducible 
biochemical activities that have been 
operationally defined as discrete 
functional elements.
ENCODE’s feature maps illustrate 
the human genome. They are 
unquestionably useful, despite the 
incomplete and ill defined nature of 
having to operationalize something 
as complex as biological function. 
Many labs will use ENCODE datasets 
without needing (or being able) 
to generate such systematic high 
quality data themselves, a sine qua 
non of useful big science investment 
in biology.
All the textbooks are wrong? 
The ENCODE summary paper [2] 
added up how much of the genome 
was covered by the mapped 
functional elements, arriving at a 
figure of 80.4% (dominated by RNA 
transcription, which alone covered 
62%). Couched in precise language 
about the proxy that was being 
counted — regions of reproducible 
biochemical activity — reporting 
these coverage statistics was 
innocuous, even pro forma for a 
genomics project. The summary 
paper also correctly noted that, with 
respect to two of the ways functional 
element had been operationalized — 
because only a few cell types were 
studied, and because thresholds 
had to be drawn — the coverage numbers were conservative 
underestimates.
In attempting to popularize the 
result and the project, in press 
releases and interviews, ENCODE 
leaders fit the results to a seductive 
‘all the textbooks are wrong’ 
narrative. The noncoding 99% of the 
human genome was described as 
an enigmatic sea of dark matter that 
had been dismissed as junk out of 
ignorance and arrogance. ENCODE 
claimed to have revolutionized our 
view of the genome by showing 
that more than 80% of the genome 
was functional, thus disproving junk 
DNA. The New York Times’ coverage 
[3] is representative of the received 
story:
“The human genome is packed 
with at least four million gene 
switches that reside in bits of 
DNA that once were dismissed 
as “junk” but that turn out to 
play critical roles in controlling 
how cells, organs and other 
tissues behave.... At least 80 
percent of this DNA is active 
and needed.”
Thus all reproducible biochemical 
events were claimed to be “critical” 
and “needed”. But ENCODE had 
not shown what fraction of these 
activities play any substantive role in 
human gene regulation, nor was the 
project designed to show that. There 
are other well-studied explanations 
for reproducible biochemical 
activities besides crucial human 
gene regulation, including residual 
activities (pseudogenes), functions 
in the molecular creatures that infest 
eukaryotic genomes (transposons, 
viruses, and other mobile elements), 
and noise. Far from disproving junk 
DNA, ENCODE’s operationalized 
definition of function included junk 
DNA.
An undignified academic squabble? 
Several critiques making these 
points (and more) have appeared 
[4–7]. Of these, Ford Doolittle’s 
piece [4] is perhaps the deepest 
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narrative failed. Besides regulatory 
DNA (promoters, enhancers, and 
such), a large fraction of mammalian 
genomes (at least 50% in humans) is 
composed of mobile DNA elements, 
most of which are defective and 
decaying. Moreover, eukaryotic 
genome sizes are too variable and 
too large to be accounted for by 
natural selection for host functions. 
Thus, genomes contain a lot of DNA 
that is not critically important for 
host functions, much of which arises 
from mobile element replication: a 
concept irreverently called ‘junk’ 
DNA. The fact that mobile elements 
autonomously replicate and spread 
explains why a host genome has 
difficulty getting rid of this DNA.
ENCODE’s reproducible 
biochemical activities do not bear 
on the concept of junk DNA because 
they do not distinguish activities 
important to human biology from 
activities expected to be found in 
junk DNA, including host suppression 
of mobile element replication, 
and mobile elements regulating 
and expressing themselves as 
they try to replicate and evade 
host surveillance. ENCODE’s 
data illuminate the battlefield, but 
ENCODE should have acknowledged 
the known combatants.
One critique, by Graur and 
colleagues [6] — angry, dogmatic, 
scattershot, sometimes inaccurate — 
garnered widespread media 
coverage because its tone played 
into the ‘undignified academic 
squabble’ cliché of science 
journalism. Attention focused on the 
squabbling more than the substance, 
and probably led some to wonder 
whether the arguments were just 
quibbling over the semantics of the 
word ‘function’.
Trying to conceptualize the forces 
that act on genome evolution is not 
just a matter of semantics. We can 
envision the human genome as a 
perfectly honed machine, or we can 
think of it as a wild landscape littered 
and layered with successions of 
decomposing molecular replicators, 
like dead weeds decaying into fertile 
soil. How much DNA does it take to 
design a human? How much DNA 
does it take to evolve a human?  
They are not the same question, and 
the gap between them is where we 
seek an understanding of genome 
evolution.The Random Genome Project: the 
missing negative control
The Doolittle [4] and Graur [6] 
critiques touch on a different sense 
in which ENCODE’s interpretation 
needs to be questioned. It’s one 
thing to distinguish human gene 
regulatory functions from other 
biological functions, such as mobile 
DNA element functions. Another 
question is whether we ought to 
accept the oft-unstated assumption, 
prevalent in genomics at present, 
that any specific and reproducible 
biochemical event must correspond 
to a meaningful biological function. 
In this view, all biochemically active 
sequences are nonrandom and 
honed by selection, and natural 
selection does not tolerate any 
wasted activities.
Another view is that biology is 
noisy. Population genetic theory 
says natural selection has limited 
power [8], so we should expect 
that every biochemical machine is 
only just good enough for its job, 
tolerating some level of background 
biochemical activity [9]. Those 
in the first camp have typically 
argued against noise by arguing 
that biochemical events are not 
just a nonspecific background haze 
over the genome, but instead occur 
at highly specific, reproducible 
locations in specific cell types. An 
example of this argument is that 
a cell-type-specific expression 
pattern is often taken to be sufficient 
evidence for functionality of a 
noncoding RNA transcript. But this 
misunderstands what we should 
expect noise to look like in a 
genome.
To clarify what noise means, 
I propose the Random Genome 
Project. Suppose we put a few 
million bases of entirely random 
synthetic DNA into a human cell, and 
do an ENCODE project on it. Will 
it be reproducibly transcribed into 
mRNA-like transcripts, reproducibly 
bound by DNA-binding proteins, 
and reproducibly wrapped around 
histones marked by specific 
chromatin modifications? I think yes.
A striking feature of genetic 
regulation is that regulatory factors 
(proteins or RNAs) generally 
recognize and bind to small sites, 
small enough that any given factor 
will find specific binding sites even in 
random DNA. Promoters, enhancers, 
splice sites, poly-A addition sites, and other functional features in 
the genome all have substantial 
random occurrence frequencies. 
These sites are not nonspecific 
in a random genome. They are 
specific sequences, albeit randomly 
occurring and not under selection for 
any function.
Would biochemical activities in the 
random genome be regulated under 
different conditions?  For example, 
would they be cell type-specific? 
Surely yes, because the regulatory 
factors themselves (such as 
transcription factors) are regulated 
and expressed in specific cell types 
and conditions.
Suppose we identified a cell-
type-specific transcription unit in 
the random genome, and we knock 
it down or out. Would we see a 
measurable molecular phenotype 
(for example, by measuring genome-
wide gene expression from the rest 
of the genome)? I think yes. Any 
biochemical activity perturbs the 
system to some degree, if only by 
soaking up regulatory factors and 
changing their free concentrations. 
When does a measurable phenotype 
stop being a mere perturbation 
and start becoming evidence of 
an important function? I am not 
convinced that there’s a qualitative 
distinction.
Even as a thought experiment, the 
Random Genome Project states a 
null hypothesis that has been largely 
absent from these discussions in 
genomics. It emphasizes that it is 
reasonable to expect reproducible 
biochemical activities — even 
measurable knockout phenotypes — 
in random unselected DNA. Could 
the Random Genome Project be 
done for real? Certainly we could 
use genome synthesis methods 
to synthesize a specific random 
sequence, and I can think of cheaper 
means since we only need any 
random sequence. To a small extent 
the experiment has already been 
done, where people have already 
measured specific biochemical 
activity (such as enhancers that 
drive specific expression patterns) in 
exogenous or random DNA, either in 
their negative controls or in in vitro 
selection experiments in random 
sequence libraries. It would be 
interesting to collate such examples. 
It would also be interesting to study 
some natural examples of large 
exogenous DNA insertions, such as 
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into nuclear DNA, or bacterial 
genome integrations into eukaryotic 
genomes (such as the Wolbachia 
genome that integrated into the 
Drosophila ananassae genome), 
although there is some danger in 
studying sequences that may have 
co-evolved with the eukaryotic 
host’s biochemical machinery.
Why big science fails even as it 
succeeds
Clearly the arguments over 
ENCODE are also fueled by 
unease over big science and small 
science approaches in biology. 
It is bewildering to see ENCODE 
take an eminently reasonable data 
generation project and spin it so 
inexpertly as a hypothesis test 
with supposedly revolutionary 
conclusions. Does it suggest that 
big science is out of control? I 
suggest the deeper problem is that 
we are not sufficiently comfortable 
with defending what big science in 
biology is for.
There are three categories of big 
science: the big experiment, the 
map, and the leading wedge. A big 
experiment is driven by a single 
question or hypothesis test, but 
requires a large scale community 
investment. Like any experiment, 
it would generally include an 
experimental design, positive and 
negative controls, and validation 
experiments that test conclusions 
from multiple angles. A failure mode 
in a big experiment is the difficulty in 
planning experiments properly in a 
committee process.
A map is a data resource — 
comprehensive, complete, closed 
ended — to be used by multiple 
groups, over a long time, for multiple 
purposes. The decision to build a 
map is a cost/benefit calculation, 
weighed against individual labs 
who are already making piecemeal 
maps in an ill coordinated fashion, 
especially when small groups lack 
technical expertise to make the map 
well. A failure mode with a map is 
to miscalculate the cost/benefit 
analysis and make a map that too 
few individual labs will use.
A leading wedge is a massed 
technology development effort, in 
an area where we need radically 
better methods. There is a driving 
goal that is visionary, but perhaps 
arbitrary. The actual long-term goal is to develop and democratize a 
breakthrough technology, making 
it cheap and effective for routine 
use in individual labs, for individual 
well designed experiments. A failure 
mode in a leading wedge is the 
inertia of the big science phase, 
failing to transition as quickly as it 
should to democratization to small 
labs.
We have been too shy to defend 
maps and leading wedges in biology. 
Maps and leading wedges are about 
enabling small science; they are 
not the science itself. Coordinated 
investment in infrastructure is 
somewhat new to our culture of 
hypothesis driven, question driven 
science. We feel a strong temptation 
to spin all big science projects in 
biology as big experiments, whereas 
the complexity of biology — its 
lack of unifying theory, its wealth of 
fascinating and crucial detail — is 
such that big experiments are 
nearly nonexistent in our field. Our 
important insights are born and 
tested in small labs.
For example, the Human Genome 
Project (HGP) was sometimes spun 
as a revolution in understanding the 
human genome, and this was wrong. 
But the project’s critics sometimes 
fell into a trap themselves, of 
not recognizing the value of the 
HGP as both a map and a leading 
wedge. The value of the human 
genome sequence as a resource is 
indisputable. A massive revolution 
in sequencing technology also 
resulted, and that technology is now 
in the hands of individual labs.
ENCODE and some of its critics 
have fallen into similar traps. In 
trying to make the result sound 
important, ENCODE’s publicity spun 
it retrospectively as a hypothesis 
test, but ENCODE was not designed 
to test anything. ENCODE is a map: 
it should have been published and 
defended as such. And while its 
critics argue over an interpretation 
that wasn’t in ENCODE’s mission 
to begin with, ENCODE’s planners 
should also recognize that as 
ENCODE now moves into a new 
funding phase, it may be headed for 
a failure mode in its actual mission. 
The cost/benefit calculation is rapidly 
changing. ENCODE’s technologies 
(all based on high throughput 
sequencing) are now widely and 
inexpensively available in individual 
labs.The next big thing
The United States government is 
now considering the Brain Activity 
Map (BAM) project, a big science 
project with the aim of recording 
every neuron in a brain. In my 
taxonomy, the Brain Activity Map 
is not a map, nor an experiment; 
it is all leading wedge. Recording 
from every neuron in a large brain 
is an arbitrary aspirational goal, 
like sending a person to the Moon. 
Neural activity is entirely open 
ended, different in every question 
we ask and every condition we 
examine. But neuroscience is in part 
technology limited, asking questions 
about neural circuits and neural 
systems using current technologies 
that record from relatively few 
neurons at once. Reaching BAM’s 
goal of recording every neuron in a 
brain will do little in itself to advance 
our understanding of brains, and 
it will not produce much in the 
way of a stable and reusable data 
resource, but it would be a landmark 
achievement in enabling individual 
neuroscientists to record thousands 
to millions of neurons simultaneously, 
in model neural systems, for a 
multitude of individual experiments. 
Recognizing that BAM is all leading 
wedge, not a map and not an 
experiment, is crucial to its planning, 
its support, and its success.
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